In Parkinson’s Disease patients develop neurological dysfunction as they lose a special kind of brain cell called dopaminergic (or dopamine) neurons. While a number of different approaches to this disease have been studied for decades, nothing has proven particularly successful in slowing its progression. As a result there has been a big need for novel thinking […]
Hope on Parkinson’s front: Japan IPSC trial 1st patient Read More »
Do the hundreds of unproven fat stem cell clinics in the U.S. like Stemgenex have a tenable future without working with the FDA? It seems less certain now in 2018 than it did in 2017, and that’s a good thing in my view. Stemgenex received an FDA warning letter yesterday that included a list of many
Sizing Up Sizzling FDA Warning Letter to Fat Stem Cell Clinic Stemgenex Read More »
There are gray areas within the larger stem cell sphere or as I called it in a recent paper “the stem cell ecosystem“, but chiropractors doing stem cell transplants is not one of them. This is unethical and risky on many levels, but the number of chiropractors selling stem cells is increasing rapidly nonetheless. Chiropractors
Chiropractors and their state boards should stop risky stem cell injections Read More »
What is the AASCP? I’ve been hearing more recently about something called the American Academy of Stem Cell Physicians (variously AAOSCP or AASCP). Its name has the sound of an organization like some traditional medical academy such as the American Academy of Internal Medicine, but my sense is that this is a totally different kind
Stem cell eye drops? Skepticism of American Academy of Stem Cell Physicians (AASCP) Read More »
The stem cell clinic industry selling unapproved “therapies” is ubiquitous and yet somehow still growing it seems. Many of us are encountering more of them including via ads and the clinics are basically all over the place. What should someone do if they see a stem cell clinic that is particularly concerning? A lot of
To report a sketchy stem cell clinic, a list of simple, concrete things to do Read More »
When you think of an ecosystem, do you imagine something like a forest or jungle full of different organisms? I usually do, but over the last few years I’ve also been thinking about this concept in a different way. I’ve been viewing the broad stem cell arena as an ecosystem. In that spirit, I’ve recently
Mapping & driving the stem cell ecosystem: key points of my new paper Read More »
By Jeanne Loring Stem cells boldly go… Last week at the New York Stem Cell Foundation (NYSCF) conference at Rockefeller University in New York City, we announced our collaborative project to study the effects of microgravity on neurons derived from patient-specific induced pluripotent stem cells. The press release is here. Susan Solomon, the CEO of
Stem Cells in Space Read More »
You probably remember Liveyon. It’s a marketer of an “umbilical cord stem cell” product that was recently recalled by the FDA. The recall was due to adverse events that may have included E. coli contamination somewhere before it was injected into patients, some of whom apparently got sick. Since it seemed like this recalled product was
Stem cell clinic supplier Liveyon tries to regenerate itself after FDA recall Read More »
Remember when the Piero Anversa situation first made news or at least when you first heard about it? In the public domain, it was back around April 2014. I didn’t even do a whole post on it, but rather it made two bullet points in a post about a set of bad overall news including the latest
Anversa debacle vs. STAP cell train wreck & what’s next Read More »
Take our poll: what will be the fates of the stem cell clinic firms sued by the FDA one year from now in October 2019? To be clear, I am asking for your predictions, not what you hope will be the situation a year from now. U.S. Stem Cell, Inc. (USRM) and California Stem Cell
Polls on futures of stem cell clinics sued by FDA Read More »